Global Rheumatoid Arthritis Market Report: 2016 Edition - New Report by Koncept Analytics - PowerPoint PPT Presentation

Loading...

PPT – Global Rheumatoid Arthritis Market Report: 2016 Edition - New Report by Koncept Analytics PowerPoint presentation | free to download - id: 824f33-NjZhN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Rheumatoid Arthritis Market Report: 2016 Edition - New Report by Koncept Analytics

Description:

The report offers an in-depth analysis of the “Global Rheumatoid Arthritis Market” segmented into global and regional market. For more mail: vikas@konceptanalytics.com – PowerPoint PPT presentation

Number of Views:8

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Rheumatoid Arthritis Market Report: 2016 Edition - New Report by Koncept Analytics


1
Global Rheumatoid Arthritis Market
----------------------------------------- 2016
View Report Details
2
View Report Details
  • Executive Summary
  • Arthritis means inflammation in a joint.
    Inflammation is a normal immune response in a
    body. It happens when the body, no longer has the
    ability to turn off the inflammatory response and
    thereby start damaging the healthy tissues of the
    body.
  • Inflammation causes redness, warmth, swelling,
    and pain within the joint. There are more than
    100 different types of arthritis, with different
    causes and treatment methods. Major
    classification of arthritis includes degenerative
    arthritis, inflammation arthritis, infectious and
    metabolic arthritis.
  • Rheumatoid arthritis or RA is classified under
    inflammatory arthritis. It is a chronic
    autoimmune disease.
  • About 1 out of every 5 people who suffer from
    rheumatoid arthritis get lumps on their skin
    called rheumatoid nodules. This disease occurs in
    4 main stages and can be diagnosed with certain
    blood tests, medical history, and imaging tests.
    There is no cure for rheumatoid arthritis, but
    there are various treatments available that
    reduce the pain like drugs, physical exercise or
    surgery.
  • The rheumatoid arthritis market is expected to
    grow in the coming years with growing demand for
    better medical facilities and more effective
    drugs.
  • The US rheumatoid arthritis market dominates the
    global market with larger number of rheumatoid
    arthritis patients.
  • The key trends of the market include increasing
    competition from anti-IL6 drugs, rising FDA
    approvals to RA drugs, use of complementary and
    alternative medicines, and increasing share of
    biosimilars.
  • The key factors driving the growth of the RA
    market includes increasing women population,
    escalating global ageing population, rising
    health care expenditure, rising cigarette
    consumption, and increasing obese population.
  • However, there are certain factors which hinder
    the growth of the rheumatoid arthritis market
    like high cost of treatment and high research and
    development cost.
  • The report offers an in-depth analysis of the
    Global Rheumatoid Arthritis Market segmented
    into global and regional market.
  • Competition is concentrated in the hands of few
    major pharmaceutical companies. Major RA
    companies that have been covered in the report
    include AbbVie, JNJ, Amgen Inc. and Pfizer Inc.

3
Global Rheumatoid Arthritis market is expected to
grow significantly in the coming years driven by
several factors including increasing female
population, escalating global health care
expenditure, rising FDA approvals, rising
cigarette consumption
Global Rheumatoid Arthritis Market by Value
(2015-2020E)
  • The revenue of the global rheumatoid arthritis
    market is expected to be recorded at US..
    billion by 2020, increasing from US.. billion in
    the year 2015. It is expected to record growth at
    a CAGR of .. for the period spanning from
    2015-2020.
  • The market for XX is expected to account for
    revenue worth US.. billion by 2020, increasing
    from US.. billion in year 2015.
  • XX is expected to record revenue worth US..
    billion by 2020, an increase from US.. billion
    in 2015.
  • XX is expected to hold the maximum revenue share
    of .. in 2016, followed by XX with .. revenue
    share in the year 2016.

Global Rheumatoid Arthritis Market by Drug Class
(2015/2020E)
Global Rheumatoid Arthritis Market Share by Drug
(2016E)
4
The regional rheumatoid arthritis markets were
driven by increasing ageing population,
prevalence of smoking, increased inactivity...
The US Rheumatoid Arthritis Market by Value
(2015-2020E)
  • The revenue of rheumatoid arthritis market in the
    US is expected to be recorded at US.. billion by
    2020, increasing from US.. billion in the year
    2015, growing at a CAGR of .. for the period
    spanning from 2015-2020.
  • The total number of patients with rheumatoid
    arthritis in the US is expected to reach ..
    million by 2020, increasing from .. million in
    the year 2015.
  • The total rheumatoid arthritis population in the
    US on XX is expected to reach .. thousand by
    2020, increasing from .. thousand populations in
    2015.
  • The population on anti-TNFs in the US is expected
    to record a growth at a CAGR of .. for the
    period spanning 2015-2020.

The US Rheumatoid Arthritis Patient Prevalence
(2015-2020E) )
The US Rheumatoid Arthritis Anti-TNF Population
(2015-2020E)
5
The global rheumatoid arthritis market is
concentrated with major pharmaceutical companies
dominating the market through new drug approval
Global Rheumatoid Arthritis Market Share by
Company (2015/2020E)
  • AbbVie had .. of the market share for the year
    2015 and is expected to record a rise of . by
    2020.
  • JNJ and PEF are expected to register an increase
    of . in their market share by 2020.
  • Enbrel produce by Amgen is expected to record ..
    of the total market share in 2016.
  • AbbVies Humira is expected to account .. of the
    revenue share in 2016 .
  • By 2020, the US population on biologic drug
    treatment is expected to reach .. thousand,
    increasing from .. thousand in the year 2015.

The US Rheumatoid Arthritis Brand (Company) Share
(2016E)
The US Rheumatoid Arthritis Biologics Population
(2015-2020E)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Rheumatoid Arthritis Market- 2016 Edition . To
know more about this report or for any customized
research requirement, please contact the
following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com
About PowerShow.com